Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Cancer Chemotherapy and Pharmacology|January 1, 1987
Pharmacokinetics of unchanged carboplatin (CBDCA) in patients with small cell lung carcinomaP A Reece, J F Bishop, I N Olver, et al.Life Sciences|January 1, 1995
Safety and tolerability of CI-979 in patients with Alzheimer's diseaseJ J Sramek, A J Sedman, P A Reece, et al.Cancer Chemotherapy and Pharmacology|January 1, 1987
Effect of L-leucine on oral melphalan kinetics in patientsP A Reece, B M Dale, R G Morris, et al.American Journal of Clinical Oncology|August 1, 1990
A phase I study of doxifluridine as a five-day stepped-dose continuous infusionI N Olver, P A Reece, J F Bishop, et al.Journal of Clinical Pharmacology|May 1, 1995
Lack of effect of tacrine administration on the anticoagulant activity of warfarinP A Reece, W R Garnett, W L Rock, et al.Therapeutic Drug Monitoring|January 1, 1989
Alteration in doxorubicin and doxorubicinol plasma concentrations with repeated courses to patientsR G Morris, P A Reece, B M Dale, et al.Cancer Chemotherapy and Pharmacology|January 1, 1988
Renal clearance and protein binding of melphalan in patients with cancerP A Reece, H S Hill, R M Green, et al.Cancer Chemotherapy and Pharmacology|January 1, 1990
Pharmacokinetic study of doxifluridine given by 5-day stepped-dose infusionP A Reece, I N Olver, R G Morris, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1989
Two- versus 24-hour infusion of cisplatin: pharmacokinetic considerationsP A Reece, I Stafford, R L Abbott, et al.British Journal of Clinical Pharmacology|June 26, 2001
Quinapril and its metabolite quinaprilat in human milkE J Begg, R A Robson, S J Gardiner, et al.Pageof 4